Streetbeat News

Regulatory

AIOT

Powerfleet, Inc. (NASDAQ:AIOT) has received clearance from the SEC regarding its recent merger with MiX Telematics Ltd. This allows Powerfleet to file its Transition Report on Form 10-KT and its Quarterly Report on Form 10-Q. The company will report its first fiscal quarter results on August 22, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:09 am

INVE

Identiv, Inc. (NASDAQ:INVE) has received approval from the Committee on Foreign Investment in the United States (CFIUS) to sell its Physical Security Business to Vitaprotech for $145 million. The transaction is expected to close within 30 days, significantly strengthening Identiv's financial position and allowing it to focus on its IoT solutions business.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:07 am

SUPN

Supernus Pharmaceuticals has resubmitted its new drug application for an apomorphine infusion device for Parkinson's disease to the FDA, with a decision expected by February 2025.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:03 am

BMY

The European Medicines Agency (EMA) has validated Bristol Myers Squibb's application to expand the use of Breyanzi for treating relapsed follicular lymphoma. This validation allows the scientific review to begin.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 11:01 am

LQDA

Liquidia announced that the FDA has granted tentative approval for YUTREPIA (Treprostinil) Inhalation Powder to treat adults with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD). The drug has met all regulatory standards but must wait for the expiration of regulatory exclusivity of a competing product before final approval.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 10:01 am

AOGO

Arogo Capital is facing a potential delisting from Nasdaq due to its low market value.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 7:26 am

VIOT

Viomi Technology has restored compliance with Nasdaq's minimum bid price standard, ensuring its continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 7:13 am

BNR

Burning Rock Biotech has announced the delisting of its American Depositary Shares (ADS) from the London Stock Exchange (LSE), effective September 18, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 6:37 am

AZN

DSNKY

Daiichi Sankyo and AstraZeneca's ENHERTU has received its eighth Breakthrough Therapy Designation from the FDA for treating specific patients with HER2 low or ultralow metastatic breast cancer. This designation is based on the results of the DESTINY-Breast06 phase 3 trial.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 6:29 am

BTCUSD

ETHUSD

OpenAI CEO Sam Altman's Worldcoin project, which uses iris-scanning technology to distribute cryptocurrency, is facing global backlash and regulatory scrutiny. Despite claims of privacy enhancement, concerns about a global biometric database have led to actions against the project in over a dozen jurisdictions. Worldcoin has implemented new measures to address these concerns and continues to grow, with its WLD token experiencing significant price fluctuations.

Portfolio Pulse from Benzinga Neuro

August 19, 2024 | 3:19 am